MedPath

A Study of Patients With AIDS Syndrome

Completed
Conditions
Lymphoma, Non-Hodgkin
HIV Infections
Sarcoma, Kaposi
Lymphoma, AIDS-Related
Registration Number
NCT00001120
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to find out why cancers develop in HIV-positive patients.

Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.

Detailed Description

AIDS-associated malignancy represents a model system for investigations of carcinogenesis. There are few human conditions in which cancer rates are of the magnitude they are in HIV infection. While studies have investigated pre-cancer markers in HIV-infected patients, they have not correlated these markers with tumor samples. This study contributes to understanding oncogenesis of HIV-associated malignancies by establishing a collection of tumors linked with pre-cancer sera and lymphocyte specimens, as well as prospective questionnaire data.

At study entry, patients receive a comprehensive physical exam. Clinic staff interview the patient to collect data regarding medication history (particularly antiretroviral exposure), diet, occupational history, substance abuse, and sexual practices. This information is used to identify behavioral and environmental factors contributing to oncogenesis. In addition, baseline blood samples are analyzed for HHV-8 and EBV levels, anti-EBV and anti-HHV-8 antibodies, CD23, Th2 cytokines, tumor growth factors, chromosomal translocations associated with NHL, and other potential predictors of malignancy. At Month 6 and annually thereafter, patient records are abstracted for data on vital status, AIDS-defining illnesses, medications, and most recent CD4+ T cell and HIV RNA levels. At Years 1, 2, and 3, patients undergo physical exams and blood tests for malignancy surveillance. Any malignancies are biopsied and analyzed for oncogene identification and virology. The medical records of patients who die on study are reviewed to determine the cause of death and to rule out unreported cancer. No treatment is provided by this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5000
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (23)

Univ of Hawaii

🇺🇸

Honolulu, Hawaii, United States

Willow Clinic

🇺🇸

Menlo Park, California, United States

San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Marin County Specialty Clinic

🇺🇸

San Rafael, California, United States

San Mateo AIDS Program / Stanford Univ

🇺🇸

Stanford, California, United States

Stanford Univ Med Ctr

🇺🇸

Stanford, California, United States

Indiana Univ Hosp

🇺🇸

Indianapolis, Indiana, United States

Charity Hosp / Tulane Univ Med School

🇺🇸

New Orleans, Louisiana, United States

Tulane Univ School of Medicine

🇺🇸

New Orleans, Louisiana, United States

Mem Sloan - Kettering Cancer Ctr

🇺🇸

New York, New York, United States

Harvard (Massachusetts Gen Hosp)

🇺🇸

Boston, Massachusetts, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

Bellevue Hosp / New York Univ Med Ctr

🇺🇸

New York, New York, United States

St Mary's Hosp (Univ of Rochester/Infectious Diseases)

🇺🇸

Rochester, New York, United States

SUNY / Erie County Med Ctr at Buffalo

🇺🇸

Buffalo, New York, United States

Univ of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

Univ of Rochester Medical Center

🇺🇸

Rochester, New York, United States

Duke Univ Med Ctr

🇺🇸

Durham, North Carolina, United States

Univ of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Case Western Reserve Univ

🇺🇸

Cleveland, Ohio, United States

MetroHealth Med Ctr

🇺🇸

Cleveland, Ohio, United States

Univ of Washington

🇺🇸

Seattle, Washington, United States

Ohio State Univ Hosp Clinic

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath